GMG
Clinical trials for GMG explained in plain language.
Never miss a new study
Get alerted when new GMG trials appear
Sign up with your email to follow new studies for GMG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare muscle disease: drug trial launches
Disease control Recruiting nowThis study tests a drug called gefurulimab in 12 children aged 6 to 18 who have generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see how the drug moves through the body, how well it works, and if it is safe. Participants will receive the drug…
Matched conditions: GMG
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
New study aims to help MG patients reduce steroid use safely
Disease control Recruiting nowThis study looks at whether people with generalized myasthenia gravis (gMG) who are already taking the drug ravulizumab can safely reduce or stop their oral steroids. About 75 adults will follow a step-by-step steroid-tapering schedule. The goal is to lower steroid doses without …
Matched conditions: GMG
Phase: PHASE4 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 02:58 UTC
-
New hope for MG patients: study tests safer drug combos
Disease control Recruiting nowThis study is testing different drug combinations to find safer and more effective treatments for people with myasthenia gravis, a condition that causes muscle weakness. About 70 adults with generalized MG will try either a new drug alone or added to their current treatment. The …
Matched conditions: GMG
Sponsor: argenx • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug combo aims to ease severe muscle weakness
Disease control Recruiting nowThis study tests whether adding empasiprubart to the standard treatment efgartigimod can further improve symptoms in people with a specific type of generalized myasthenia gravis (gMG). About 70 adults who still have partial symptoms despite efgartigimod will receive the combinati…
Matched conditions: GMG
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated May 07, 2026 18:41 UTC